Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.94)
# 2,816
Out of 4,814 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $13.15 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $6.85 | +903.65% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $0.29 | +2,352.70% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.91 | +1,548.53% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $60 | $1.02 | +5,782.35% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $60.52 | -42.17% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $0.23 | +21,545.02% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $130 → $80 | $0.54 | +14,739.55% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $6.01 | +1,647.09% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $37.19 | -22.01% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $3.06 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.15
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $6.85
Upside: +903.65%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $0.29
Upside: +2,352.70%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.91
Upside: +1,548.53%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $60
Current: $1.02
Upside: +5,782.35%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $60.52
Upside: -42.17%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $0.23
Upside: +21,545.02%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $130 → $80
Current: $0.54
Upside: +14,739.55%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $6.01
Upside: +1,647.09%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $37.19
Upside: -22.01%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $3.06
Upside: -